Parkinson disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 13,023 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Robotic Gait Rehabilitation in Parkinson's Disease

  NCT05218187· Indiana University· Updated 5 Nov 2026

  “The PI was no longer able to successfully recruit participants and funding was depleted.”Registry text, quoted unchanged. Source

• Terminated

  Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach

  NCT06378619· Consorci Sanitari de l'Alt Penedès i Garraf· Updated 28 Oct 2026

  “Poor recruitment”Registry text, quoted unchanged. Source

• Terminated

  Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  NCT02897063· Vanderbilt University Medical Center· Updated 23 Oct 2026

  “enrollment goal was not met.”Registry text, quoted unchanged. Source

• Terminated

  Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

  NCT06003608· Nimble Science Ltd.· Updated 20 Oct 2026

  “Study recruitment phase exceeded the time allotted”Registry text, quoted unchanged. Source

• Suspended

  Terazosin And Metabolic Energetics in Parkinson's Disease

  NCT07464028· Ergun Y. Uc· Updated 9 Oct 2026

  “Study not funded”Registry text, quoted unchanged. Source

• Withdrawn

  Terazosin And Metabolic Engagement in Parkinson's Disease

  NCT07288450· Nandakumar Narayanan· Updated 7 Oct 2026

  “Not Funded”Registry text, quoted unchanged. Source

• Terminated

  Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

  NCT07313176· Britannia Pharmaceuticals Ltd.· Updated 2 Oct 2026

  “Following a reassessment, it was concluded that continuation of the study would no longer achieve its scientific objectives originally set out for the study.”Registry text, quoted unchanged. Source

• Withdrawn

  The Parkinson's Disease Case-Control Study

  NCT06848192· Westlake University· Updated 29 Sept 2026

  “Due to challenges in obtaining faecal samples from patients with Parkinson's disease, a population frequently affected by constipation.”Registry text, quoted unchanged. Source

• Suspended

  Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

  NCT05482126· University of Alabama at Birmingham· Updated 24 Sept 2026

  “Suspending since no longer working participants at this time or enrolling new ones.”Registry text, quoted unchanged. Source

• Suspended

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Updated 21 Sept 2026

  “Administrative”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

  NCT07642908· University of Michigan· Source

• Voluntary Activation During Isokinetic Contractions in Subjects With Neuromotor Disorders

  NCT04607174· Istituto Auxologico Italiano· Source

• Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation

  NCT04897256· Oregon Health and Science University· Source

• Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes

  NCT07604883· International Institute of Molecular and Cell Biology in Warsaw· Source

• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· Hoffmann-La Roche· Source

• Adapting rHIRE and Sleep Monitoring in Parkinson's Disease

  NCT07498296· University of Colorado, Denver· Source

• Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease

  NCT05348837· University of Colorado, Denver· Source

• Longitudinal Observation of Neurodegeneration in Parkinson's Disease Using Molecular Imaging and Blood Biomarkers

  NCT07919262· Xuanwu Hospital, Beijing· Source

• Comparative Effects of Virtual Reality and Proprioceptive Neuromuscular Facilitation in Patients With Parkinson's Disease

  NCT07308093· Lahore University of Biological and Applied Sciences· Source

• Parkinson's Disease in Type 1 Gaucher Disease

  NCT07886879· Icahn School of Medicine at Mount Sinai· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 23
• Organoids 19
• Mendelian Randomization Analysis 66
• CRISPR-Cas Systems 15
• Gene Expression Profiling 75
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 7
• Exome Sequencing 12
• Proteomics 70
• Metabolomics 34
• Mass Spectrometry 12
• Flow Cytometry 4
• Immunohistochemistry 49
• Liquid Biopsy 3
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 100
• Magnetic Resonance Imaging 364
• Machine Learning 141
• Deep Learning 71
• Cohort Studies 182
• Genome-Wide Association Study 83

• Differential and directional body coupling analysis in Parkinsonian gait.

  PLoS One, Nov 2026

• Resource allocation under uncertainty and equity constraints in Parkinson's disease care: An econometrically grounded machine learning framework.

  PLoS One, Nov 2026

• Early Detection of Bladder Cancer Using Advanced Feature Engineering and Swarm Intelligence Optimization on EHRs.

  IEEE Trans Biomed Eng, Nov 2026

• Early health technology assessment of machine learning-enabled remote monitoring for advanced Parkinson disease.

  Int J Technol Assess Health Care, Oct 2026

• Identification and experimental validation of candidate biomarkers for Parkinson's Disease through integrated bioinformatics, Mendelian randomization, and machine learning.

  Mol Biol Rep, Oct 2026

• Exploring the Potential Neurotoxic Links Between 6PPD/6PPD-Q and Parkinson's Disease Through Network Toxicology and Multi-Dimensional Bioinformatics Analysis.

  Neurotox Res, Oct 2026

• Cross-species molecular stratification enables T cell receptor diagnosis of Parkinson's disease.

  Genome Med, Sept 2026

• Explicit Mechanistic Causal Analyses or Interventional Trials Are Required for Objective, Clinical, Voice-Based Parkinson Disease Characterization.

  J Med Internet Res, Sept 2026

• From beta thresholds to learned control: machine learning in adaptive deep brain stimulation.

  J Clin Neurosci, Sept 2026

• MIND-based cortical similarity networks reveal distinct cortical alterations in motor subtypes of Parkinson's disease.

  Neuroimage, Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.